Emtora Biosciences: Funding, Investors & Team (Oct 2026)
Emtora Biosciences is a life science company that commercializes a new formulation of an immunosuppressant as a prostate cancer drug. The company developing a novel formulation of rapamycin, eRapa for use in preventing the onset and recurrence of cancer. It manufactures a drug to slow the aging process and its efficacy in treating age-related diseases. The eRapa is the only pharmaceutical agent to demonstrate significantly increased healthspan and lifespan in rodent models, and Science, Nature, and Time magazines proclaimed the discovery of a special formulation of rapamycin to extend one’s life and health span among the most significant and exciting scientific breakthroughs of 2009.
Emtora Biosciences has raised $16.9M across 1 funding round on record, the most recent a Grant of $16.9M announced in Aug 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Emtora Biosciences Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Emtora Biosciences Funding Rounds
Emtora Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
Emtora Biosciences Funding Compared to Other Biotechnology Startups
Emtora Biosciences' latest round of $16.9M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Emtora Biosciences in Biotechnology and San Antonio
Companies Similar to Emtora Biosciences
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Emtora Biosciences Funding FAQs
What does Emtora Biosciences do?
Emtora Biosciences is a life science company that commercializes a new formulation of an immunosuppressant as a prostate cancer drug. The company developing a novel formulation of rapamycin, eRapa for use in preventing the onset and recurrence of cancer. It manufactures a drug to slow the aging process and its efficacy in treating age-related diseases. The eRapa is the only pharmaceutical agent to demonstrate significantly increased healthspan and lifespan in rodent models, and Science, Nature, and Time magazines proclaimed the discovery of a special formulation of rapamycin to extend one’s life and health span among the most significant and exciting scientific breakthroughs of 2009.
How much funding has Emtora Biosciences raised?
Emtora Biosciences has raised $16.9M across 1 round on record. The most recent is a Grant of $16.9M announced in Aug 2022.
When did Emtora Biosciences last raise funding?
Emtora Biosciences' most recent funding round on record is a Grant of $16.9M, announced in Aug 2022.
Who is the CEO of Emtora Biosciences?
Dan Hargrove is listed as CEO at Emtora Biosciences.
Where is Emtora Biosciences headquartered?
Emtora Biosciences is based in San Antonio, Texas, United States.
How many employees does Emtora Biosciences have?
Emtora Biosciences is in the 1-10 employee band.
How does Emtora Biosciences' funding compare to other Biotechnology startups?
Emtora Biosciences' latest round of $16.9M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Emtora Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Emtora Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.